June 15, 2017 / 4:08 PM / a month ago

BRIEF-Teva Pharmaceuticals USA says recalls one lot of Paliperidone ER tablets

2 Min Read

June 15 (Reuters) - Teva Pharmaceutical Industries Ltd

* Teva Pharmaceuticals USA Inc initiated a voluntary recall to retail-level for one lot of paliperidone extended-release tablets, 3mg, 90 count bottles

* Teva Pharmaceuticals USA Inc - The lot of paliperidone extended-release tablets, 3mg, 90 count bottles was distributed under Actavis Pharma Inc label

* Teva Pharmaceuticals USA Inc says the recall is being carried out due to failing test results for dissolution

* Teva Pharmaceuticals USA Inc says it cannot at this time exclude potential for additional tablets to be below specification

* Teva - Based on Teva's investigation, likelihood of consuming two or more consecutive doses with affected product is low

* Teva - In addition, no post marketing adverse events have been received to date for lack of effectiveness for this recalled lot

* Teva says it has issued an urgent drug recall letter to its direct accounts and has made arrangements for impacted product to be returned to inmar Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below